The European Commission Grants Marketing Authorization for VUMERITY® (diroximel fumarate) as Oral Treatment for Relapsing-Remitting Multiple Sclerosis
VUMERITY is a next-generation oral fumarate treatment for people with relapsing-remitting MS with established efficacy…
TransNusa Expands Regional Network With Launch of Jakarta-Penang Route
PLN Strengthens Its Pathway to the Global Carbon Market Through Energy Transition Investments
IMPC Commits Rp250 billion (USD 15 million) to Build ASEAN’s Leading Polymer Training Center, Partnering with SKZ-German Plastics Center
Bitzero Holdings Inc. Announces Commencement of Trading on Canadian Securities Exchange
OTTICA By Optimax Eyewear Launches New Online Platform for Luxury Eyewear Shopping